Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins in Treatment of Acute Coronary Syndrome (NSTE-ACS)
2009-012850-19Phase 3Active
- Sponsor
- ASL Bari
- Start
- Jul 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in non–ST-segment elevation acute coronary syndrome (NSTE-ACS) comparing Rosuvastatin 20 mg with Atorvastatin 80 mg (2 arms). Primary endpoint: Effectiveness of rosuvastatin vs atorvastatin on hs-CRP reduction and plaque stabilization. Started Jul 2009; status: active.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on 2009-012850-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012850-19.